Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged a...

FDA Recall #D-0507-2025 — Class II — June 19, 2025

Recall #D-0507-2025 Date: June 19, 2025 Classification: Class II Status: Ongoing

Product Description

Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61

Reason for Recall

Defective container; blister packaging inadequately sealed.

Recalling Firm

The Harvard Drug Group LLC — Dublin, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

23,232 cartons

Distribution

Nationwide

Code Information

Lot# M05205, Exp Date 10/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated